Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly C Claeys

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Emergency Medicine Clinics of North America|April 19, 2024
The Diagnosis and Treatment of Adult Urinary Tract Infections in the Emergency DepartmentRobert Redwood, Kimberly C Claeys
Drugs in Context|February 27, 2023
Leveraging diagnostic stewardship within antimicrobial stewardship programmesKimberly C Claeys, Melissa D Johnson
Infectious Diseases and Therapy|January 23, 2021
Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream InfectionAshley Barlow, Emily L Heil, Kimberly C Claeys
JAMA Internal Medicine|July 10, 2023
Increasing Evidence That Diagnostic Stewardship May Improve Antibiotic UseDaniel J Morgan, Surbhi Leekha, Kimberly C Claeys
Current Opinion in Infectious Diseases|July 11, 2023
Diagnostic stewardship: what impacts antibiotics use?K C Coffey, Daniel J Morgan, Kimberly C Claeys
The Journal of Applied Laboratory Medicine|January 3, 2025
What Is Diagnostic Stewardship?Kimberly C Claeys, K C Coffey, Daniel J Morgan
Pharmacotherapy|February 16, 2020
Imipenem-Cilastatin-Relebactam: A Novel β-Lactam-β-Lactamase Inhibitor Combination for the Treatment of Multidrug-Resistant Gram-Negative InfectionsJordan R Smith, Jeffrey M Rybak, Kimberly C Claeys
Open Forum Infectious Diseases|October 24, 2025
Beyond Accuracy: Methodological Advances for Assessing the Clinical Impact of Infectious Disease DiagnosticsKimberly C Claeys, Andrea M Prinzi, Tristan T Timbrook
JAMA Internal Medicine|June 10, 2024
What Should I Know About Recurrent UTIs in Older Women?Sonali D Advani, Kimberly C Claeys, Nazema Y Siddiqui
Expert Opinion on Pharmacotherapy|October 22, 2020
An evaluation of meropenem/vaborbactam for the treatment of nosocomial pneumoniaLauren M Groft, Kimberly C Claeys, Emily L Heil
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Emergency Medicine Clinics of North America|April 19, 2024
The Diagnosis and Treatment of Adult Urinary Tract Infections in the Emergency DepartmentRobert Redwood, Kimberly C Claeys
Drugs in Context|February 27, 2023
Leveraging diagnostic stewardship within antimicrobial stewardship programmesKimberly C Claeys, Melissa D Johnson
Infectious Diseases and Therapy|January 23, 2021
Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream InfectionAshley Barlow, Emily L Heil, Kimberly C Claeys
JAMA Internal Medicine|July 10, 2023
Increasing Evidence That Diagnostic Stewardship May Improve Antibiotic UseDaniel J Morgan, Surbhi Leekha, Kimberly C Claeys
Current Opinion in Infectious Diseases|July 11, 2023
Diagnostic stewardship: what impacts antibiotics use?K C Coffey, Daniel J Morgan, Kimberly C Claeys
The Journal of Applied Laboratory Medicine|January 3, 2025
What Is Diagnostic Stewardship?Kimberly C Claeys, K C Coffey, Daniel J Morgan
Pharmacotherapy|February 16, 2020
Imipenem-Cilastatin-Relebactam: A Novel β-Lactam-β-Lactamase Inhibitor Combination for the Treatment of Multidrug-Resistant Gram-Negative InfectionsJordan R Smith, Jeffrey M Rybak, Kimberly C Claeys
Open Forum Infectious Diseases|October 24, 2025
Beyond Accuracy: Methodological Advances for Assessing the Clinical Impact of Infectious Disease DiagnosticsKimberly C Claeys, Andrea M Prinzi, Tristan T Timbrook
JAMA Internal Medicine|June 10, 2024
What Should I Know About Recurrent UTIs in Older Women?Sonali D Advani, Kimberly C Claeys, Nazema Y Siddiqui
Expert Opinion on Pharmacotherapy|October 22, 2020
An evaluation of meropenem/vaborbactam for the treatment of nosocomial pneumoniaLauren M Groft, Kimberly C Claeys, Emily L Heil
Pageof 10